HIGHFDA DEVICE

Foundation Medicine FoundationOne Liquid CDx Recall 2022 Reminds Clinicians to Check CDx Pages (18 U

Foundation Medicine issued a recall affecting 18 FoundationOne Liquid CDx tests, including 17 in the United States and 1 overseas. The defect is the absence of the companion diagnostic CDx Claims Page in reports. Amended claims pages were distributed within seven days. Stop use immediately and follow manufacturer instructions.

Official notice
Foundation MedicineHealth & Personal CareMedical DevicesF1LCDx - TECH-0009 version 6.0ORD-XXX6703-01 (JP)ORD-XXXX411-01 (US)

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
November 8, 2022
Status
ACTIVE
Severity
7/10

Quick Facts at a Glance

Recall Date
November 8, 2022
Hazard Level
HIGH
Brand
Foundation Medicine
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Foundation Medicine
Product type
Companion Diagnostic Test
Model numbers
F1LCDx - TECH-0009 version 6.0, ORD-XXX6703-01 (JP), ORD-XXXX411-01 (US), ORD-XXXX128-01 (US), ORD-XXXX061-01 (US), ORD-XXXX270-01 (US), ORD-XXXXX94-01 (US), ORD-XXXX058-01 (US) +11 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    November 8, 2022

  2. Reported by FDA DEVICE

    December 3, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Reports were sent to customers without the companion diagnostic (CDx) Claims Page. Claims pages were distributed via amended reports within 7 days of the issue occurrence.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Foundation Medicine, Inc. or your healthcare provider for instructions. Notification method: Letter

About This Product

FoundationOne Liquid CDx is a liquid biopsy tumor profiling test used to identify genomic alterations for cancer treatment decisions.

Why This Is Dangerous

The defect is the absence of the CDx Claims Page in reports, which could affect the completeness of diagnostic information presented to clinicians.

Industry Context

This recall is not described as part of a broader industry pattern.

Real-World Impact

Clinicians may rely on incomplete reports, potentially influencing treatment decisions.

Practical Guidance

How to identify if yours is affected

  1. 1. Review ORD numbers listed in the recall.
  2. 2. Compare with ORD numbers on your report.
  3. 3. Verify if your report includes the CDx Claims Page.

Where to find product info

Look for ORD-XXXX-XX identifiers on the report or accompanying documentation.

What timeline to expect

Remedies typically follow a recall process via manufacturer, with refunds/replacements coordinated within weeks.

If the manufacturer is unresponsive

  • Escalate to Foundation Medicine support.
  • File a complaint with FDA if needed.

How to prevent similar issues

  • Verify CDx claims pages accompany reports in the future.
  • Confirm presence of all required pages before relying on results.
  • Keep a copy of recall notices and your ORD numbers.

Documentation advice

Maintain copies of the recall notice, ORD numbers, and all correspondence with the manufacturer.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: FoundationOne Liquid CDx (F1LCDx) TECH-0009 version 6.0. Quantity: 18 units (17 US, 1 OUS). Distribution: US nationwide in states including AL, AZ, CA, FL, GA, IL, IN, KS, KY, ME, MN, MO, MS, MT, NC, NJ, NV, NY, OK, PA, PR, SD, TN, TX, UT, VA, WA, WI, WV. OUS international to Japan and Singapore. Model numbers include F1LCDx - TECH-0009 version 6.0 and ORD numbers such as ORD-XXX6703-01 (JP), ORD-XXXX411-01 (US), ORD-XXXX128-01 (US), ORD-XXXX061-01 (US), ORD-XXXX270-01 (US), ORD-XXXXX94-01 (US), ORD-XXXX058-01 (US), ORD-XXXX099-01 (US), ORD-XXXX089-01 (US), ORD-XXXX252-01 (US), ORD-XX

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • US distribution across 25 states plus PR
  • Overseas: Japan, Singapore
  • ORD test numbers listed

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
7/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Details

Model Numbers
F1LCDx - TECH-0009 version 6.0
ORD-XXX6703-01 (JP)
ORD-XXXX411-01 (US)
ORD-XXXX128-01 (US)
ORD-XXXX061-01 (US)
+14 more
Affected States
ALL
Report Date
December 3, 2025
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more